U.S. Gas Utilities Stock News

NYSE:FITB
NYSE:FITBBanks

Is Fifth Third (FITB) Quietly Turning Fintech Innovation Into Balance Sheet Strength?

Recently, Fifth Third Bancorp was honored by Global Finance as a Top Financial Innovator for its Newline embedded finance platform, while its net interest income and earnings per share growth remained comparatively soft but supported by accelerating tangible book value per share. This combination of fintech recognition and a strengthening tangible asset base suggests the bank is balancing innovation with underlying balance sheet resilience. We’ll now explore how Fifth Third’s Newline...
NasdaqGS:MDGL
NasdaqGS:MDGLBiotechs

Is Madrigal Pharmaceuticals (MDGL) Undervalued On Its New siRNA Milestone?

Madrigal Pharmaceuticals (MDGL) stock is drawing attention after partner Suzhou Ribo Life Science reported the first candidate drug nomination in its siRNA program targeting liver diseases, including metabolic dysfunction associated steatohepatitis, or MASH. See our latest analysis for Madrigal Pharmaceuticals. The latest siRNA milestone arrives after a period of index reshuffling for Madrigal Pharmaceuticals, with the stock moving into larger Russell benchmarks and posting a 1 month share...
NYSE:ABCB
NYSE:ABCBBanks

Ameris Bancorp (ABCB) Could Be 4% Below Fair Value On Its Growth Narrative

Ameris Bancorp stock moves without a clear single catalyst Ameris Bancorp (ABCB) has drawn investor attention after recent trading, even without a specific headline event to point to. This has prompted a closer look at how the stock has been performing recently. See our latest analysis for Ameris Bancorp. Ameris Bancorp’s recent share price slip of 0.7% in the latest session comes after a solid run, with a 30 day share price return of 5.5% and a year to date share price return of 21.9%. The 1...
NasdaqGM:APPF
NasdaqGM:APPFSoftware

Is AppFolio's (APPF) Board Refresh and Index Exit Reframing Its AI Property-Management Narrative?

AppFolio, Inc. recently saw two long-serving directors, including its Chairman, retire from the Board, while appointing Diya Jolly and Michael Yang as new Class I directors and naming Winifred Webb as Lead Independent Director, alongside refreshed committee assignments effective June 29, 2026. At the same time, AppFolio was removed from the Russell 1000 Defensive and Russell 1000 Growth-Defensive indexes, a shift that may influence how index-tracking funds hold or trade the stock. We’ll now...
NasdaqGS:ROKU
NasdaqGS:ROKUEntertainment

Roku (ROKU) Could Be 7% Undervalued As Fox Eyes A $22b Acquisition

Roku stock and the Fox acquisition: what is driving attention now Roku (ROKU) is back in focus after Fox Corp announced plans to acquire the streaming platform in a deal valued at about US$22b. This development is putting fresh attention on the stock’s current pricing. See our latest analysis for Roku. Beyond the Fox offer, Roku’s recent share price performance has been strong. The 30-day share price return is 15.5% and the 90-day share price return is 39.83%, while the 1-year total...
NYSE:ES
NYSE:ESElectric Utilities

Massachusetts Grid-Scale Batteries Might Change The Case For Investing In Eversource Energy (ES)

Eversource Energy, alongside National Grid and Unitil, has filed long-term contracts for three utility-scale battery storage projects in Massachusetts, totaling 1,068 MW and 4,472 MWh of capacity expected online by 2030 to support cleaner, more flexible grid operations. This large storage build-out marks a key step in Massachusetts’ push toward 5 GW of storage by 2030, highlighting Eversource’s expanding role in enabling clean peaking capacity and easing transmission congestion in Greater...
NasdaqGS:RPRX
NasdaqGS:RPRXPharmaceuticals

Royalty Pharma (RPRX) Could Be 2% Undervalued On Russell 1000 Defensive Index Addition

Royalty Pharma (RPRX) has just been added to both the Russell 1000 Value-Defensive Index and the Russell 1000 Defensive Index, a shift that often attracts closer attention from index-tracking and passive funds. See our latest analysis for Royalty Pharma. That index inclusion comes after a period of strong momentum for Royalty Pharma, with a 90-day share price return of 20.67%, a year-to-date share price return of 48.74%, and a 1-year total shareholder return of 66.26%. If you are using this...
NasdaqGS:RMBS
NasdaqGS:RMBSSemiconductor

Rambus (RMBS) Could Be 27% Undervalued After Its Recent Pullback

Rambus (RMBS) recently shifted across several Russell indices, moving into the Russell 1000 and Russell Midcap groupings while exiting multiple Russell 2000 benchmarks, a technical reshuffle that can influence institutional ownership patterns. See our latest analysis for Rambus. That reshuffle comes after a sharp pullback, with Rambus posting a 7 day share price return of down 20.2% and a 30 day share price return of down 27.1%, even as the 1 year total shareholder return sits at 62.5%. This...
NYSE:PRG
NYSE:PRGConsumer Finance

Does PROG Holdings’ (PRG) Russell Index Debut Reveal a Deeper Shift in Its Investor Base?

In late June 2026, PROG Holdings, Inc. (NYSE: PRG) was added to multiple Russell growth and small‑cap benchmarks, including the Russell 2000 Growth, Russell 2500 Growth, and Russell 3000 Growth indices. This broad index inclusion places PROG Holdings on the radar of index-tracking funds and institutional investors that benchmark against these Russell indices. We’ll now examine how PROG Holdings’ multi-index inclusion, particularly in the Russell 2000 Growth, might shape the company’s...
NYSE:PM
NYSE:PMTobacco

ZYN’s FDA Modified-Risk Label Could Be A Game Changer For Philip Morris International (PM)

Philip Morris International Inc. recently announced that the U.S. Food and Drug Administration granted Modified Risk Tobacco Product orders for 20 ZYN nicotine pouch variants, authorizing marketing claims that switching from cigarettes to ZYN lowers the risk of several serious smoking-related diseases. This makes ZYN the first nicotine pouch range in the U.S. with MRTP status, potentially strengthening Philip Morris International’s position in smoke-free products as regulators differentiate...
NasdaqGS:SMTC
NasdaqGS:SMTCSemiconductor

Is Semtech (SMTC) A Bargain On Its New Credit Agreement?

Semtech (SMTC) recently entered a new Credit Agreement that includes a $360 million undrawn revolving credit facility and an uncommitted incremental term loan option, replacing its prior bank arrangement with extended maturities. See our latest analysis for Semtech. Despite the new Credit Agreement and recent index changes that saw Semtech move into several Russell large and midcap indices, short term momentum has cooled, with the 7 day share price return down 21.90% and the 1 month share...
NasdaqGS:PI
NasdaqGS:PISemiconductor

The Bull Case For Impinj (PI) Could Change Following Its Upcoming Q2 Results And Q3 Outlook

In early July 2026, Impinj announced it had previously scheduled the release of its second-quarter 2026 results and third-quarter outlook for July 29, alongside a conference call and webcast for investors. At the same time, optimism across the semiconductor sector and Impinj’s multi-year gains highlighted how broader industry sentiment can meaningfully influence the company’s valuation assessments and insider trading activity. With sector-wide optimism supporting Impinj’s recent move, we’ll...
NYSE:ENVA
NYSE:ENVAConsumer Finance

Enova International (ENVA) Beat First Quarter Estimates, Does It Look Fully Valued?

Enova International (ENVA) has returned to investor focus after a first quarter earnings report that exceeded analyst expectations on both revenue and profitability, with the stock posting a sharp move higher following the release. See our latest analysis for Enova International. Beyond the initial earnings reaction, Enova International’s momentum has been strong, with a 40.39% 30 day share price return and a 104.43% 1 year total shareholder return. This points to a material reset in how the...
NYSE:HEI
NYSE:HEIAerospace & Defense

Nuclear Energy Stocks For AI Power Demand Including Constellation Energy

With inflation worries tied to oil prices, tighter central bank stances and energy security back in focus, many investors are rethinking how they get exposure to long term power demand. Nuclear energy stocks sit at the crossroads of reliable baseload electricity and efforts to limit fuel price shocks, and the Nuclear Energy Stocks screener helps you filter this space quickly, from uranium suppliers to reactor operators. In this article, you will see three screened nuclear energy stocks and...
NYSE:DOW
NYSE:DOWChemicals

Dow (DOW) Faces Rising Earnings Expectations, Is The Stock Still Cheap?

Recent attention on Dow (DOW) is tied to expectations for higher earnings and revenue ahead of its July 23, 2026 report, even as the stock recently lagged a rising broader market. See our latest analysis for Dow. At a share price of $28.64, Dow has recently seen a 1-day share price return of 4.79% and a 7-day share price return of 4.68%. This follows a 30-day share price decline of 15.69% and a 90-day share price decline of 27.09%. Its 1-year total shareholder return of 3.71% contrasts with a...
NYSE:SPXC
NYSE:SPXCMachinery

SPX Technologies (SPXC) Joins Russell Value Indexes, Is It A Bargain?

SPX Technologies (SPXC) is at the center of a broad Russell index reshuffle, with the stock moving into several large cap and value benchmarks while exiting multiple growth and small cap indices. See our latest analysis for SPX Technologies. The recent Russell reshuffle and fund rebalancing coincide with a sharp pullback, with SPX Technologies' share price falling 5.75% in the last day and 10.74% over the week. However, its 1 year total shareholder return of 28.32% and 3 year total...
NYSE:CHE
NYSE:CHEHealthcare

Chemed (CHE) Leaves Russell Growth Indexes, Does It Look Fairly Valued?

Why Chemed’s Index Removals Matter for Investors Chemed (CHE) has been dropped from several Russell growth oriented benchmarks, including the Russell 1000 Growth and Russell 3000 Growth indexes, an event that can influence passive fund flows and near term trading activity. See our latest analysis for Chemed. Despite Chemed’s removal from several Russell growth indexes, the stock’s recent trading has been firm, with a 1 month share price return of 9.91% and a 90 day share price return of...
NasdaqGS:GRAB
NasdaqGS:GRABTransportation

3 Penny Stocks With Strong Balance Sheets Worth A Closer Look

Global markets are wrestling with higher oil prices, sticky inflation signals, and rising bond yields, which puts real pressure on weaker companies that rely heavily on cheap money to survive. That is exactly why the Elite Penny Stocks screener focuses on balance sheet strength, not just hype. By filtering for smaller stocks that still have the cash and financial resilience to pursue their growth plans, this approach narrows the field to companies that can keep investing even as borrowing...
NasdaqGS:DXCM
NasdaqGS:DXCMMedical Equipment

Is DexCom’s (DXCM) Sensor Recall Exposing Deeper Questions About Its Quality Controls and Data Systems?

DexCom, Inc. previously initiated a voluntary Class II recall of specific Dexcom G7 continuous glucose monitoring sensor lots that had been stolen during the destruction process, including devices with improper sterilization and potential sensor inaccuracies that could lead to infections or incorrect glucose readings across multiple countries. The incident highlights vulnerabilities in DexCom’s supply chain controls and data monitoring, as the company is relying on app usage data rather than...
NYSE:GWRE
NYSE:GWRESoftware

Is Guidewire Software (GWRE) Undervalued Following Its Russell Value Index Inclusion?

Guidewire Software (GWRE) was recently added to multiple Russell value benchmarks, including the Russell 1000 Value and Russell 3000 Value. This index reshuffle can affect how index funds and benchmarked investors treat the stock. See our latest analysis for Guidewire Software. Guidewire Software’s recent inclusion in several Russell value indices comes after a mixed stretch for investors, with a 7 day share price return of 11.39% standing against a year to date share price decline of 26.95%...
NYSE:SARO
NYSE:SAROAerospace & Defense

How Investors Are Reacting To StandardAero (SARO) Broad Russell Index Removal And Shifting Shareholder Base

In late June 2026, StandardAero, Inc. (NYSE:SARO) was removed from multiple Russell growth and midcap indices, including the Russell 1000 Growth, Russell 3000 Growth, Russell 2500 Growth, Russell Midcap Growth and Russell Small Cap Comp Growth benchmarks. This broad index exclusion can meaningfully alter the shareholder base as index-tracking funds rebalance, potentially increasing trading volumes and near-term liquidity pressures around the stock. Against this backdrop of broad Russell...
NasdaqGM:AMAL
NasdaqGM:AMALBanks

Amalgamated Financial (AMAL) Looks Fully Valued After Russell Index Additions

Index additions put Amalgamated Financial in focus Amalgamated Financial (AMAL) has been added to multiple Russell growth-oriented indexes, a change that can influence how index funds and institutional investors allocate capital to the stock. See our latest analysis for Amalgamated Financial. At a share price of $45.80, Amalgamated Financial has seen its short term share price return soften over the last week. Its 30 day and year to date share price returns, alongside a strong multi year...
NasdaqGS:UPBD
NasdaqGS:UPBDSpecialty Retail

Upbound Group (UPBD) Could Be 28% Undervalued After Russell Index Removal

Upbound Group (UPBD) was removed from several Russell indices on June 27, 2026. This type of index change can influence index-tracking flows and prompt investors to reassess how the stock fits in diversified portfolios. See our latest analysis for Upbound Group. At a share price of $20.51, Upbound Group has seen a 12.26% 1 month share price return and an 18.21% year to date share price return, but its 1 year total shareholder return is down 15.12%. This suggests that recent momentum contrasts...
NYSE:KR
NYSE:KRConsumer Retailing

CVS Stock And Inflation Trends Investors Should Watch Right Now

Inflation is no longer just about what you pay at the pump. With energy prices easing after the U.S. Iran ceasefire, attention is shifting to stickier costs like rent, medical care, and services, all while consumer inflation expectations climb and the Federal Reserve keeps markets guessing on rates. That mix can help some stocks and hurt others, depending on how closely their earnings are tied to these price trends. This article breaks down 3 stocks from our Inflation Momentum Stocks With Key...